SU1516013A3 - Способ получени термически стабильной кристаллической аддитивной соли с серной кислотой 7-[ @ -(2-аминотиазол-4-ил)- @ -(Z)-метоксииминоацетамидо]-3-[(1-метил-1-пирролидинио)-метил]-3-цефем-4-карбоксилата - Google Patents

Способ получени термически стабильной кристаллической аддитивной соли с серной кислотой 7-[ @ -(2-аминотиазол-4-ил)- @ -(Z)-метоксииминоацетамидо]-3-[(1-метил-1-пирролидинио)-метил]-3-цефем-4-карбоксилата Download PDF

Info

Publication number
SU1516013A3
SU1516013A3 SU864027914A SU4027914A SU1516013A3 SU 1516013 A3 SU1516013 A3 SU 1516013A3 SU 864027914 A SU864027914 A SU 864027914A SU 4027914 A SU4027914 A SU 4027914A SU 1516013 A3 SU1516013 A3 SU 1516013A3
Authority
SU
USSR - Soviet Union
Prior art keywords
methyl
sulfuric acid
cephem
alpha
carboxylate
Prior art date
Application number
SU864027914A
Other languages
English (en)
Russian (ru)
Inventor
А.Каплан Муррей
В.Худима Томас
А.Липпер Роберт
Original Assignee
Бристоль-Мейерз Компани (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бристоль-Мейерз Компани (Фирма) filed Critical Бристоль-Мейерз Компани (Фирма)
Application granted granted Critical
Publication of SU1516013A3 publication Critical patent/SU1516013A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
SU864027914A 1985-08-05 1986-08-04 Способ получени термически стабильной кристаллической аддитивной соли с серной кислотой 7-[ @ -(2-аминотиазол-4-ил)- @ -(Z)-метоксииминоацетамидо]-3-[(1-метил-1-пирролидинио)-метил]-3-цефем-4-карбоксилата SU1516013A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (1)

Publication Number Publication Date
SU1516013A3 true SU1516013A3 (ru) 1989-10-15

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
SU864027914A SU1516013A3 (ru) 1985-08-05 1986-08-04 Способ получени термически стабильной кристаллической аддитивной соли с серной кислотой 7-[ @ -(2-аминотиазол-4-ил)- @ -(Z)-метоксииминоацетамидо]-3-[(1-метил-1-пирролидинио)-метил]-3-цефем-4-карбоксилата

Country Status (34)

Country Link
JP (1) JPH0615548B2 (fr)
KR (1) KR930003121B1 (fr)
AR (1) AR243894A1 (fr)
AT (1) AT390957B (fr)
AU (1) AU597262B2 (fr)
BE (1) BE905219A (fr)
CA (1) CA1284994C (fr)
CH (1) CH675581A5 (fr)
CS (2) CS276849B6 (fr)
CY (1) CY1614A (fr)
DD (2) DD254941A5 (fr)
DE (1) DE3626375A1 (fr)
DK (1) DK162053C (fr)
EG (1) EG18003A (fr)
ES (1) ES2002112A6 (fr)
FI (1) FI84484C (fr)
FR (1) FR2585705B1 (fr)
GB (1) GB2179936B (fr)
GR (1) GR862055B (fr)
HK (1) HK99691A (fr)
HU (1) HU196602B (fr)
IE (1) IE59222B1 (fr)
IL (1) IL79608A (fr)
IT (1) IT1197067B (fr)
LU (2) LU86540A1 (fr)
MY (1) MY102212A (fr)
NL (1) NL8601991A (fr)
OA (1) OA08672A (fr)
PT (1) PT83134B (fr)
SE (1) SE469633B (fr)
SG (1) SG79791G (fr)
SU (1) SU1516013A3 (fr)
YU (1) YU45793B (fr)
ZA (1) ZA865842B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988010263A1 (fr) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Composes cristallins de cephalosporine, procede de preparation et produits intermediaires pour la preparation de ces composes
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (fr) * 1989-03-06 1999-11-16 Murray A. Kaplan Dihydrochlorure de bmy-28142 lyophilise pour usage parenteral
CA2101571A1 (fr) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Dihydrate cristallise d'un sel de cephalosporine dihydrate; compositions injectables a base de ce compose
EP0638573A1 (fr) * 1993-08-10 1995-02-15 Lucky Ltd. Hydrates crystallins d'une céphalosporine et procédé pour leur préparation
CN100543027C (zh) 2003-12-23 2009-09-23 桑多斯有限公司 制备用于合成头孢菌素的中间体的方法
WO2008056221A2 (fr) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Sel de sulfate cristallin d'antibiotique céphalosporine
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (fr) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporines
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Па тент.. US № 4406899. кл. 424-246, опублик. 1985.., . *

Also Published As

Publication number Publication date
ES2002112A6 (es) 1988-07-16
OA08672A (en) 1989-03-31
SE469633B (sv) 1993-08-09
GB8618989D0 (en) 1986-09-17
CA1284994C (fr) 1991-06-18
AR243894A1 (es) 1993-09-30
FI863155A0 (fi) 1986-08-01
CS276849B6 (en) 1992-08-12
DK371886D0 (da) 1986-08-04
SG79791G (en) 1991-11-15
HUT41802A (en) 1987-05-28
DK162053C (da) 1992-02-10
JPS62103090A (ja) 1987-05-13
IL79608A0 (en) 1986-11-30
YU137186A (en) 1987-12-31
CH675581A5 (fr) 1990-10-15
AT390957B (de) 1990-07-25
EG18003A (en) 1991-08-30
DD268395A5 (de) 1989-05-31
GB2179936A (en) 1987-03-18
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
CY1614A (en) 1992-07-10
AU6069486A (en) 1987-02-12
NL8601991A (nl) 1987-03-02
AU597262B2 (en) 1990-05-31
IT1197067B (it) 1988-11-25
YU45793B (sh) 1992-07-20
IL79608A (en) 1991-07-18
CS276717B6 (en) 1992-08-12
DK162053B (da) 1991-09-09
MY102212A (en) 1992-05-15
FR2585705A1 (fr) 1987-02-06
SE8603308D0 (sv) 1986-08-04
IT8621409A1 (it) 1988-02-04
PT83134B (pt) 1989-07-31
IT8621409A0 (it) 1986-08-04
FI84484B (fi) 1991-08-30
BE905219A (fr) 1987-02-04
IE862078L (en) 1987-02-05
IE59222B1 (en) 1994-01-26
HK99691A (en) 1991-12-13
DD254941A5 (de) 1988-03-16
ATA211086A (de) 1990-01-15
GR862055B (en) 1986-12-24
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
LU86540A1 (fr) 1987-03-06
FR2585705B1 (fr) 1989-01-13
FI84484C (fi) 1991-12-10
PT83134A (en) 1986-09-01
ZA865842B (en) 1987-04-29
HU196602B (en) 1988-12-28
GB2179936B (en) 1989-04-26
DK371886A (da) 1987-02-06
LU88574I2 (fr) 1995-03-01
FI863155A (fi) 1987-02-06
DE3626375A1 (de) 1987-02-12

Similar Documents

Publication Publication Date Title
SU1516013A3 (ru) Способ получени термически стабильной кристаллической аддитивной соли с серной кислотой 7-[ @ -(2-аминотиазол-4-ил)- @ -(Z)-метоксииминоацетамидо]-3-[(1-метил-1-пирролидинио)-метил]-3-цефем-4-карбоксилата
US4910301A (en) Cefepime cephalosporin salts
RU1787158C (ru) Способ получени цефемовых соединений или их аддитивных солей с кислотами
CS244940B2 (en) Production method of /s/-epimeres of esters of 7beta-malonamido -7alfa-methoxy-3-tetrazolythiomethyl-1-dethia-loxa-3-cefem-4-carboxyl acid
KR910000420B1 (ko) 결정성 세펨-산 부가염의 제조방법
JPS6016994A (ja) セフアロスポリン誘導体
JPH045038B2 (fr)
AU621040B2 (en) Crystallized cephem-acid addition salts, and a process for the preparation thereof
AU2006300882B2 (en) Crystalline sodium salt of cephalosporin antibiotic
US4727070A (en) 3-Propenzl cephalosporin isomer separation process and derivative
US5409918A (en) Crystalline cephem acid addition salts and process for their preparation
US5244891A (en) Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) Cephalosporin salts and injectable compositions
JPS6115885A (ja) セフタジイムの製造
SU925251A3 (ru) Способ получени кристаллической формы D-конфигурации полуторной натриевой соли 7 @ -/ @ -карбокси- @ -(п-оксифенил) ацетамидо/-7 @ -метокси-3-(1-метилтетразол-5-ил)-тиометил-1-оксадетиа-3-цефем-4-карбоновой кислоты
US4124762A (en) 7-[(Pyridylthiomethyl)phenyl]acetamido-cephalosporin derivatives
IE48572B1 (en) Production of sodium cefamandole
SU571187A3 (ru) Способ получени производных 2аминометил-4,6-дигелоидофенола
JPS58183695A (ja) 経口投与用活性セフロキシム誘導体、その製造方法およびその医薬組成物
JPH04244088A (ja) セファロスポリン誘導体
NO780835L (no) Fremgangsmaate for fremstilling av cefalosporinderivater